✦ LIBER ✦

Emerging Opioid Abuse in Terminal Cancer Patients Taking Oral Transmucosal Fentanyl Citrate for Breakthrough Pain

✍ Scribed by Juan M. Núñez-Olarte; Pablo Álvarez-Jiménez

Book ID: 113742753
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 48 KB
Volume: 42
Category: Article
ISSN: 0885-3924
DOI: 10.1016/j.jpainsymman.2011.07.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Newer Generation Fentanyl Transmucosal P

Newer Generation Fentanyl Transmucosal Products for Breakthrough Pain in Opioid-Tolerant Cancer Patients

✍ Frank Elsner, Giovambattista Zeppetella, Josep Porta-Sales, Ignacio Tagarro PhD 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 173 KB

S613 SUBLINGUAL FENTANYL TABLETS FOR BRE

S613 SUBLINGUAL FENTANYL TABLETS FOR BREAKTHROUGH CANCER PAIN: EFFICACY IN NON-RESPONDERS TO ORAL TRANSMUCOSAL FENTANYL CITRATE

✍ M. Überall; G. Müller-Schwefe 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 56 KB

Oral transmucosal fentanyl citrate (OTFC

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

✍ Russell K Portenoy; Richard Payne; Paul Coluzzi; James W Raschko; Alan Lyss; Mic 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Opioids in non-cancer pain: Breakthrough

Opioids in non-cancer pain: Breakthrough pain in patients with chronic noncancer pain: Impact on quality of life and the effects of oral transmucosal fentanyl citrate

✍ D. Taylor; S. Chun; J. Reinking; M. Stegman; L. Webster 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Oral transmucosal fentanyl citrate for t

Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics

✍ Mystakidou, K. 📂 Article 📅 2005 🏛 SAGE Publications 🌐 English ⚖ 184 KB

4254 Efficacy and patient preference for

4254 Efficacy and patient preference for intranasal fentanyl spray (INFS) versus oral transmucosal fentanyl citrate (OTFC) for breakthrough cancer pain – an open-label crossover trial

✍ S. Mercadante; L. Popper 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB